Andrew Charlwood
a31907aa1f
- Remove app_v2.py (consolidated into pathways_app.py), fix __init__ import - Add DimSearchTerm.csv, drug_indication_clusters.csv, drug_snomed_mapping_enriched.csv as reference data for SNOMED-based indication matching - Add snomed_indication_mapping_query.sql (source for embedded cluster mapping) - Update DESIGN_SYSTEM.md, RALPH_PROMPT.md, ralph.ps1, uv.lock
146 lines
12 KiB
CSV
146 lines
12 KiB
CSV
Drug,Indication,Cluster_ID,Cluster_Description,NICE_TA_Reference
|
|
ABATACEPT,Rheumatoid arthritis,RARTH_COD,Rheumatoid arthritis diagnosis codes,TA195/TA280/TA375
|
|
ABATACEPT,Rheumatoid arthritis,C19RARTH_COD,Rheumatoid arthritis disorders (broader),TA195/TA280/TA375
|
|
ABATACEPT,Psoriatic arthritis,PSORIASIS_COD,Psoriasis codes (for psoriatic arthritis),TA568
|
|
ACALABRUTINIB,Chronic lymphocytic leukaemia,CLL_COD,Chronic lymphocytic leukaemia,TA689
|
|
ADALIMUMAB,Rheumatoid arthritis,RARTH_COD,Rheumatoid arthritis diagnosis codes,TA130/TA195/TA375
|
|
ADALIMUMAB,Rheumatoid arthritis,C19RARTH_COD,Rheumatoid arthritis disorders (broader),TA130/TA195/TA375
|
|
ADALIMUMAB,Psoriasis,PSORIASIS_COD,Psoriasis codes,TA146/TA455
|
|
ADALIMUMAB,Psoriasis,CUST_CMMS_PSORIASIS,Psoriasis (Cambridge Multimorbidity),TA146/TA455
|
|
ADALIMUMAB,Psoriatic arthritis,PSORIASIS_COD,Psoriasis codes (for psoriatic arthritis),TA125/TA199
|
|
ADALIMUMAB,Crohn's disease,CROHNS_COD,Crohn's disease codes,TA187
|
|
ADALIMUMAB,Ulcerative colitis,ULCCOLITIS_COD,Ulcerative colitis codes,TA329
|
|
ADALIMUMAB,Ankylosing spondylitis,ANKSPON_COD,Ankylosing spondylitis codes,TA143/TA383
|
|
AFLIBERCEPT,Diabetic macular oedema,DM_COD,Diabetes mellitus codes,TA346
|
|
AFLIBERCEPT,Diabetic macular oedema,DMTYPE2AUDIT_COD,Type 2 diabetes codes,TA346
|
|
ALIROCUMAB,Hypercholesterolaemia,HYPERCHOL_COD,Hypercholesterolaemia codes,TA393
|
|
APREMILAST,Psoriasis,PSORIASIS_COD,Psoriasis codes,TA419
|
|
APREMILAST,Psoriasis,CUST_CMMS_PSORIASIS,Psoriasis (Cambridge Multimorbidity),TA419
|
|
APREMILAST,Psoriatic arthritis,PSORIASIS_COD,Psoriasis codes (for psoriatic arthritis),TA433
|
|
ATEZOLIZUMAB,Cancer (various),CANCER_COD,Cancer codes (various),TA492/TA520/TA525
|
|
BARICITINIB,Rheumatoid arthritis,RARTH_COD,Rheumatoid arthritis diagnosis codes,TA466
|
|
BARICITINIB,Rheumatoid arthritis,C19RARTH_COD,Rheumatoid arthritis disorders (broader),TA466
|
|
BARICITINIB,Atopic dermatitis,ECZEMA_COD,Atopic dermatitis/eczema codes,TA681
|
|
BEVACIZUMAB,Cancer (various),CANCER_COD,Cancer codes (various),TA584/TA666
|
|
BIMEKIZUMAB,Psoriasis,PSORIASIS_COD,Psoriasis codes,TA723
|
|
BIMEKIZUMAB,Psoriasis,CUST_CMMS_PSORIASIS,Psoriasis (Cambridge Multimorbidity),TA723
|
|
BOTULINUM A TOXIN,Spasticity (various),SPASTICITY_COD,Spasticity and movement disorder codes,No specific TA
|
|
BRODALUMAB,Psoriasis,PSORIASIS_COD,Psoriasis codes,TA511
|
|
BRODALUMAB,Psoriasis,CUST_CMMS_PSORIASIS,Psoriasis (Cambridge Multimorbidity),TA511
|
|
CERTOLIZUMAB PEGOL,Rheumatoid arthritis,RARTH_COD,Rheumatoid arthritis diagnosis codes,TA375/TA415
|
|
CERTOLIZUMAB PEGOL,Rheumatoid arthritis,C19RARTH_COD,Rheumatoid arthritis disorders (broader),TA375/TA415
|
|
CERTOLIZUMAB PEGOL,Psoriasis,PSORIASIS_COD,Psoriasis codes,TA574
|
|
CERTOLIZUMAB PEGOL,Psoriatic arthritis,PSORIASIS_COD,Psoriasis codes (for psoriatic arthritis),TA445
|
|
CERTOLIZUMAB PEGOL,Ankylosing spondylitis,ANKSPON_COD,Ankylosing spondylitis codes,TA383
|
|
DENOSUMAB,Osteoporosis,OSTEO_COD,Osteoporosis codes,TA204
|
|
DENOSUMAB,Bone metastases,CANCER_COD,Cancer codes (bone metastases),TA265
|
|
DEXAMETHASONE,Diabetic macular oedema,DM_COD,Diabetes mellitus codes,TA349/TA824
|
|
DEXAMETHASONE,Diabetic macular oedema,DMTYPE2AUDIT_COD,Type 2 diabetes codes,TA349/TA824
|
|
DEXAMETHASONE,Multiple myeloma,MM_COD,Multiple myeloma codes,TA311/TA380
|
|
DEXAMETHASONE,Uveitis,UVEITIS_COD,Uveitis codes,TA460
|
|
DIMETHYL FUMARATE,Multiple sclerosis,MS_COD,Multiple sclerosis codes,TA320
|
|
DIMETHYL FUMARATE,Psoriasis,PSORIASIS_COD,Psoriasis codes,TA475
|
|
DOCETAXEL,Cancer (various),CANCER_COD,Cancer codes (breast/lung/prostate),TA006/TA030/TA101
|
|
DUPILUMAB,Atopic dermatitis,ECZEMA_COD,Atopic dermatitis/eczema codes,TA534
|
|
DUPILUMAB,Asthma,ASTHMA_COD,Asthma codes,TA751
|
|
ERENUMAB,Migraine,MIGRAINE_COD,Migraine codes,TA682
|
|
ETANERCEPT,Rheumatoid arthritis,RARTH_COD,Rheumatoid arthritis diagnosis codes,TA036/TA130/TA195
|
|
ETANERCEPT,Rheumatoid arthritis,C19RARTH_COD,Rheumatoid arthritis disorders (broader),TA036/TA130/TA195
|
|
ETANERCEPT,Psoriasis,PSORIASIS_COD,Psoriasis codes,TA103
|
|
ETANERCEPT,Psoriasis,CUST_CMMS_PSORIASIS,Psoriasis (Cambridge Multimorbidity),TA103
|
|
ETANERCEPT,Psoriatic arthritis,PSORIASIS_COD,Psoriasis codes (for psoriatic arthritis),TA104/TA199
|
|
ETANERCEPT,Ankylosing spondylitis,ANKSPON_COD,Ankylosing spondylitis codes,TA143/TA383
|
|
EVOLOCUMAB,Hypercholesterolaemia,HYPERCHOL_COD,Hypercholesterolaemia codes,TA394
|
|
FARICIMAB,Diabetic macular oedema,DM_COD,Diabetes mellitus codes,TA799
|
|
FARICIMAB,Diabetic macular oedema,DMTYPE2AUDIT_COD,Type 2 diabetes codes,TA799
|
|
FILGOTINIB,Rheumatoid arthritis,RARTH_COD,Rheumatoid arthritis diagnosis codes,TA676
|
|
FILGOTINIB,Rheumatoid arthritis,C19RARTH_COD,Rheumatoid arthritis disorders (broader),TA676
|
|
FILGOTINIB,Ulcerative colitis,ULCCOLITIS_COD,Ulcerative colitis codes,TA792
|
|
FLUOCINOLONE,Atopic dermatitis,ECZEMA_COD,Atopic dermatitis/eczema codes,TA081
|
|
FLUOCINOLONE,Diabetic macular oedema,DM_COD,Diabetes mellitus codes,TA301
|
|
FLUOCINOLONE,Uveitis,UVEITIS_COD,Uveitis codes,TA590
|
|
FLUOCINOLONE ACETONIDE,Atopic dermatitis,ECZEMA_COD,Atopic dermatitis/eczema codes,TA081
|
|
FLUOCINOLONE ACETONIDE,Diabetic macular oedema,DM_COD,Diabetes mellitus codes,TA301
|
|
FLUOCINOLONE ACETONIDE,Uveitis,UVEITIS_COD,Uveitis codes,TA590
|
|
FREMANEZUMAB,Migraine,MIGRAINE_COD,Migraine codes,TA631/TA764
|
|
GALCANEZUMAB,Migraine,MIGRAINE_COD,Migraine codes,TA659
|
|
GOLIMUMAB,Rheumatoid arthritis,RARTH_COD,Rheumatoid arthritis diagnosis codes,TA225/TA375
|
|
GOLIMUMAB,Rheumatoid arthritis,C19RARTH_COD,Rheumatoid arthritis disorders (broader),TA225/TA375
|
|
GOLIMUMAB,Psoriatic arthritis,PSORIASIS_COD,Psoriasis codes (for psoriatic arthritis),TA220
|
|
GOLIMUMAB,Ulcerative colitis,ULCCOLITIS_COD,Ulcerative colitis codes,TA329
|
|
GOLIMUMAB,Ankylosing spondylitis,ANKSPON_COD,Ankylosing spondylitis codes,TA233/TA383
|
|
GUSELKUMAB,Psoriasis,PSORIASIS_COD,Psoriasis codes,TA521
|
|
GUSELKUMAB,Psoriasis,CUST_CMMS_PSORIASIS,Psoriasis (Cambridge Multimorbidity),TA521
|
|
GUSELKUMAB,Psoriatic arthritis,PSORIASIS_COD,Psoriasis codes (for psoriatic arthritis),TA711/TA815
|
|
IDARUCIZUMAB,Anticoagulant reversal,ANTICOAG_COD,Anticoagulation-related codes,No specific TA
|
|
IMATINIB,Chronic myeloid leukaemia,CML_COD,Chronic myeloid leukaemia codes,TA050/TA070/TA251
|
|
IMATINIB,Gastrointestinal stromal tumours,GIST_COD,Gastrointestinal stromal tumour codes,TA086/TA326
|
|
IMMUNOGLOBULIN,Immunodeficiency (various),IMMUNODEF_COD,Primary/secondary immunodeficiency codes,TA481/TA482
|
|
INFLIXIMAB,Rheumatoid arthritis,RARTH_COD,Rheumatoid arthritis diagnosis codes,TA036/TA130/TA195
|
|
INFLIXIMAB,Rheumatoid arthritis,C19RARTH_COD,Rheumatoid arthritis disorders (broader),TA036/TA130/TA195
|
|
INFLIXIMAB,Psoriasis,PSORIASIS_COD,Psoriasis codes,TA134
|
|
INFLIXIMAB,Psoriasis,CUST_CMMS_PSORIASIS,Psoriasis (Cambridge Multimorbidity),TA134
|
|
INFLIXIMAB,Psoriatic arthritis,PSORIASIS_COD,Psoriasis codes (for psoriatic arthritis),TA104/TA199
|
|
INFLIXIMAB,Crohn's disease,CROHNS_COD,Crohn's disease codes,TA040/TA187
|
|
INFLIXIMAB,Ulcerative colitis,ULCCOLITIS_COD,Ulcerative colitis codes,TA163/TA329
|
|
INFLIXIMAB,Ankylosing spondylitis,ANKSPON_COD,Ankylosing spondylitis codes,TA383
|
|
IXEKIZUMAB,Psoriasis,PSORIASIS_COD,Psoriasis codes,TA442
|
|
IXEKIZUMAB,Psoriasis,CUST_CMMS_PSORIASIS,Psoriasis (Cambridge Multimorbidity),TA442
|
|
IXEKIZUMAB,Psoriatic arthritis,PSORIASIS_COD,Psoriasis codes (for psoriatic arthritis),TA537
|
|
IXEKIZUMAB,Ankylosing spondylitis,ANKSPON_COD,Ankylosing spondylitis codes,TA718
|
|
LUCENTIS,Diabetic macular oedema,DM_COD,Diabetes mellitus codes,Biosimilar of ranibizumab
|
|
LUCENTIS,Diabetic macular oedema,DMTYPE2AUDIT_COD,Type 2 diabetes codes,Biosimilar of ranibizumab
|
|
OBINUTUZUMAB,Chronic lymphocytic leukaemia,CLL_COD,Chronic lymphocytic leukaemia codes,TA343/TA663
|
|
OBINUTUZUMAB,Follicular lymphoma,FL_COD,Follicular lymphoma codes,TA472/TA513/TA629
|
|
OCTREOTIDE,Neuroendocrine tumours,NET_COD,Neuroendocrine tumour codes,No specific TA
|
|
OMALIZUMAB,Asthma,ASTHMA_COD,Asthma codes,TA133/TA278
|
|
OMALIZUMAB,Chronic urticaria,URTICARIA_COD,Urticaria codes,TA339
|
|
RANIBIZUMAB,Diabetic macular oedema,DM_COD,Diabetes mellitus codes,TA274
|
|
RANIBIZUMAB,Diabetic macular oedema,DMTYPE2AUDIT_COD,Type 2 diabetes codes,TA274
|
|
REMICADE,Rheumatoid arthritis,RARTH_COD,Rheumatoid arthritis diagnosis codes,Brand name for infliximab
|
|
REMICADE,Crohn's disease,CROHNS_COD,Crohn's disease codes,Brand name for infliximab
|
|
REMICADE,Ulcerative colitis,ULCCOLITIS_COD,Ulcerative colitis codes,Brand name for infliximab
|
|
REMICADE,Psoriasis,PSORIASIS_COD,Psoriasis codes,Brand name for infliximab
|
|
RILUZOLE,Motor neurone disease,MND_COD,Motor neurone disease codes,TA020
|
|
RISANKIZUMAB,Psoriasis,PSORIASIS_COD,Psoriasis codes,TA596
|
|
RISANKIZUMAB,Psoriasis,CUST_CMMS_PSORIASIS,Psoriasis (Cambridge Multimorbidity),TA596
|
|
RISANKIZUMAB,Psoriatic arthritis,PSORIASIS_COD,Psoriasis codes (for psoriatic arthritis),TA803
|
|
RITUXIMAB,Rheumatoid arthritis,RARTH_COD,Rheumatoid arthritis diagnosis codes,TA126/TA195
|
|
RITUXIMAB,Rheumatoid arthritis,C19RARTH_COD,Rheumatoid arthritis disorders (broader),TA126/TA195
|
|
RITUXIMAB,Non-Hodgkin's lymphoma,NHL_COD,Non-Hodgkin's lymphoma codes,TA037/TA065/TA110
|
|
RITUXIMAB,Chronic lymphocytic leukaemia,CLL_COD,Chronic lymphocytic leukaemia codes,TA174/TA193/TA359
|
|
RITUXIMAB,ANCA-associated vasculitis,VASCULITIS_COD,Vasculitis codes,TA308
|
|
RIXATHON,Rheumatoid arthritis,RARTH_COD,Rheumatoid arthritis diagnosis codes,Biosimilar of rituximab
|
|
RIXATHON,Non-Hodgkin's lymphoma,NHL_COD,Non-Hodgkin's lymphoma codes,Biosimilar of rituximab
|
|
SACITUZUMAB,Triple-negative breast cancer,BREASTCA_COD,Breast cancer codes,TA819
|
|
SARILUMAB,Rheumatoid arthritis,RARTH_COD,Rheumatoid arthritis diagnosis codes,TA485
|
|
SARILUMAB,Rheumatoid arthritis,C19RARTH_COD,Rheumatoid arthritis disorders (broader),TA485
|
|
SECUKINUMAB,Psoriasis,PSORIASIS_COD,Psoriasis codes,TA350/TA734
|
|
SECUKINUMAB,Psoriasis,CUST_CMMS_PSORIASIS,Psoriasis (Cambridge Multimorbidity),TA350/TA734
|
|
SECUKINUMAB,Psoriatic arthritis,PSORIASIS_COD,Psoriasis codes (for psoriatic arthritis),TA445
|
|
SECUKINUMAB,Ankylosing spondylitis,ANKSPON_COD,Ankylosing spondylitis codes,TA407/TA719
|
|
TERIPARATIDE,Osteoporosis,OSTEO_COD,Osteoporosis codes,TA087/TA161
|
|
TILDRAKIZUMAB,Psoriasis,PSORIASIS_COD,Psoriasis codes,No TA match found
|
|
TILDRAKIZUMAB,Psoriasis,CUST_CMMS_PSORIASIS,Psoriasis (Cambridge Multimorbidity),No TA match found
|
|
TOCILIZUMAB,Rheumatoid arthritis,RARTH_COD,Rheumatoid arthritis diagnosis codes,TA198/TA247/TA375
|
|
TOCILIZUMAB,Rheumatoid arthritis,C19RARTH_COD,Rheumatoid arthritis disorders (broader),TA198/TA247/TA375
|
|
TOCILIZUMAB,Juvenile idiopathic arthritis,JIA_COD,Juvenile idiopathic arthritis codes,TA238/TA373
|
|
TOCILIZUMAB,Giant cell arteritis,GCA_COD,Giant cell arteritis codes,TA518
|
|
TOFACITINIB,Rheumatoid arthritis,RARTH_COD,Rheumatoid arthritis diagnosis codes,TA480
|
|
TOFACITINIB,Rheumatoid arthritis,C19RARTH_COD,Rheumatoid arthritis disorders (broader),TA480
|
|
TOFACITINIB,Psoriatic arthritis,PSORIASIS_COD,Psoriasis codes (for psoriatic arthritis),TA543
|
|
TOFACITINIB,Ulcerative colitis,ULCCOLITIS_COD,Ulcerative colitis codes,TA547
|
|
UPADACITINIB,Rheumatoid arthritis,RARTH_COD,Rheumatoid arthritis diagnosis codes,TA665/TA744
|
|
UPADACITINIB,Rheumatoid arthritis,C19RARTH_COD,Rheumatoid arthritis disorders (broader),TA665/TA744
|
|
UPADACITINIB,Psoriatic arthritis,PSORIASIS_COD,Psoriasis codes (for psoriatic arthritis),TA768
|
|
UPADACITINIB,Atopic dermatitis,ECZEMA_COD,Atopic dermatitis/eczema codes,TA814
|
|
UPADACITINIB,Ankylosing spondylitis,ANKSPON_COD,Ankylosing spondylitis codes,TA829
|
|
UPADACITINIB,Ulcerative colitis,ULCCOLITIS_COD,Ulcerative colitis codes,TA856
|
|
USTEKINUMAB,Psoriasis,PSORIASIS_COD,Psoriasis codes,TA180/TA455
|
|
USTEKINUMAB,Psoriasis,CUST_CMMS_PSORIASIS,Psoriasis (Cambridge Multimorbidity),TA180/TA455
|
|
USTEKINUMAB,Psoriatic arthritis,PSORIASIS_COD,Psoriasis codes (for psoriatic arthritis),TA340
|
|
USTEKINUMAB,Crohn's disease,CROHNS_COD,Crohn's disease codes,TA456
|
|
USTEKINUMAB,Ulcerative colitis,ULCCOLITIS_COD,Ulcerative colitis codes,TA633
|
|
VEDOLIZUMAB,Ulcerative colitis,ULCCOLITIS_COD,Ulcerative colitis codes,TA342
|
|
VEDOLIZUMAB,Crohn's disease,CROHNS_COD,Crohn's disease codes,TA352
|